SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-18-052587
Filing Date
2018-09-28
Accepted
2018-09-28 17:01:35
Documents
2
Period of Report
2018-09-19

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2142
2 POA DOCUMENT poa.txt EX-24.3_811133 1829
  Complete submission text file 0001209191-18-052587.txt   5295
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Issuer) CIK: 0001087294 (see all company filings)

IRS No.: 000000000
SIC: 2834 Pharmaceutical Preparations

Mailing Address 111 TENTH AVENUE SUITE 200 NASHVILLE TN 37203
Business Address
Galante Joseph C (Reporting) CIK: 0001632384 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33637 | Film No.: 181094820